Showing results (11-20 of 205) with videos related to
Sort By:
Pageof 21
Frontiers in Oncology|February 11, 2020
Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer ProgressionZheng Wang, Yicheng Zhao, Zhiqiang An, et al.Journal of Industrial Microbiology & Biotechnology|November 24, 2019
Apc.LaeA and Apc.VeA of the velvet complex govern secondary metabolism and morphological development in the echinocandin-producing fungus Aspergillus pachycristatusNan Lan, Qun Yue, Zhiqiang An, et al.Expert Opinion on Biological Therapy|October 27, 2022
Antibody therapeutics for epithelial ovarian cancerMason Ruiz, Ningyan Zhang, Anil K Sood, et al.Antibody Therapeutics|April 30, 2021
T-cell receptor mimic (TCRm) antibody therapeutics against intracellular proteinsYixiang Xu, Georgina To'a Salazar, Ningyan Zhang, et al.NPJ Vaccines|December 22, 2017
Antibody therapies for the prevention and treatment of viral infectionsGeorgina Salazar, Ningyan Zhang, Tong-Ming Fu, et al.Biochemistry and Biophysics Reports|September 29, 2017
Crk II silencing down-regulates IGF-IR and inhibits migration and invasion of prostate cancer cellsPooja Dhupkar, Huang Zhao, Kalpana Mujoo, et al.Molecules (Basel, Switzerland)|February 23, 2020
Identification of Secondary Metabolites from <i>Aspergillus pachycristatus</i> by Untargeted UPLC-ESI-HRMS/MS and Genome MiningBruno Perlatti, Nan Lan, Yongying Jiang, et al.Protein & Cell|July 23, 2017
Molecular and functional analysis of monoclonal antibodies in support of biologics developmentXin Wang, Zhiqiang An, Wenxin Luo, et al.Current Opinion in Virology|December 24, 2021
Recent progress in development of monoclonal antibodies against human cytomegalovirusXiaohua Ye, Zhiqiang Ku, Ningyan Zhang, et al.Oncoimmunology|September 20, 2018
Proteinase-nicked IgGs: an unanticipated target for tumor immunotherapyRobert E Jordan, Xuejun Fan, Georgina Salazar, et al.Pageof 21